| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.00M | 1.01M | 190.31K | 23.95K | 63.68K | 114.97K |
| Gross Profit | 396.34K | 403.08K | 181.29K | -146.37K | -209.88K | -24.78K |
| EBITDA | 0.00 | 144.81K | -600.60K | -836.10K | -1.22M | -488.88K |
| Net Income | 143.78K | 143.78K | -506.61K | -724.97K | -1.24M | -338.79K |
Balance Sheet | ||||||
| Total Assets | 641.11K | 641.11K | 24.68K | 89.29K | 441.52K | 132.40K |
| Cash, Cash Equivalents and Short-Term Investments | 75.27K | 75.27K | 4.58K | 65.05K | 415.73K | 99.21K |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 300.00K |
| Total Liabilities | 686.08K | 686.08K | 553.85K | 505.88K | 365.68K | 678.88K |
| Stockholders Equity | -44.96K | -44.96K | -529.17K | -416.60K | 75.84K | -546.47K |
Cash Flow | ||||||
| Free Cash Flow | 70.68K | 70.68K | -60.46K | -350.69K | -195.78K | 90.04K |
| Operating Cash Flow | 70.68K | 70.68K | -60.46K | -350.69K | -195.78K | 90.04K |
| Investing Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financing Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | 512.30K | 0.00 |
333D Limited has reported that the market value of its Bitcoin treasury holdings stood at $228,838 as at 1 February 2026, representing an impairment of $141,661, or 13.6% of the consolidated group’s total assets, thereby triggering its continuous disclosure obligations under ASX Listing Rule 3.1. The company attributed the decline in the Australian dollar value of its Bitcoin position to a combination of cryptocurrency price volatility and a strengthening Australian dollar against the US dollar, and noted that it does not currently hedge its cryptocurrency or foreign exchange exposures, meaning investors should expect ongoing variability in reported valuations as part of its broader digital asset treasury strategy.
The most recent analyst rating on (AU:T3D) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on 333D Limited stock, see the AU:T3D Stock Forecast page.
333D Limited reported its sixth consecutive quarter of growth in cash receipts, generating $330,917 from digital asset management contracts in the December quarter, reflecting a 3.92% increase and underscoring the success of its strategic pivot into healthcare-focused digital asset management. The company recorded net operating cash outflows of $99,180 on quarterly expenditure of about $430,097, ended the period with combined cash and Bitcoin holdings of $993,691, and highlighted progress in its BioScan 360 collaboration, having successfully stored full body MRI scan data on the blockchain with plans to scale this decentralised, patient-controlled data solution across the preventative healthcare market.
The most recent analyst rating on (AU:T3D) stock is a Hold with a A$0.05 price target. To see the full list of analyst forecasts on 333D Limited stock, see the AU:T3D Stock Forecast page.
333D Limited has announced a change in the director’s interest, specifically involving Dr. Richard Petty, who has acquired 1,000,000 performance rights as part of the company’s Long Term Incentive Plan. This acquisition was made without cash consideration, indicating a strategic move to align the director’s interests with the company’s long-term goals, potentially impacting the company’s governance and stakeholder confidence.
333D Limited has announced a change in the director’s interest, specifically involving Dr. Nigel Finch. The change involves the acquisition of 750,000 performance rights by Saki Partners (Services) Pty Ltd, a company controlled by Dr. Finch, as part of the company’s Long Term Incentive Plan. This move increases the total performance rights held by Saki Partners to 2,250,000, reflecting the company’s strategy to incentivize its leadership.